4.8 Article

Liver-specific deletion of histone deacetylase 3 disrupts metabolic transcriptional networks

Journal

EMBO JOURNAL
Volume 27, Issue 7, Pages 1017-1028

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/emboj.2008.51

Keywords

chromatin; Hdac3; histone acetylation; metabolism

Funding

  1. NCI NIH HHS [R01-CA77274, R01-CA64140, R01 CA077274, P30 CA068485, T32 CA009385, R01 CA064140, CA68485, T32 CA009582] Funding Source: Medline
  2. NIDDK NIH HHS [5P30DK58404, P30 DK058404] Funding Source: Medline

Ask authors/readers for more resources

Histone deacetylase 3 (Hdac3) is an enzymatic component of transcriptional repression complexes recruited by the nuclear hormone receptors. Inactivation of Hdac3 in cancer cell lines triggered apoptosis, and removal of Hdac3 in the germ line of mice caused embryonic lethality. Therefore, we deleted Hdac3 in the postnatal mouse liver. These mice developed hepatomegaly, which was the result of hepatocyte hypertrophy, and these morphological changes coincided with significant imbalances between carbohydrate and lipid metabolism. Loss of Hdac3 triggered changes in gene expression consistent with inactivation of repression mediated by nuclear hormone receptors. Loss of Hdac3 also increased the levels of Ppar gamma 2, and treatment of these mice with a Ppar gamma antagonist partially reversed the lipid accumulation in the liver. In addition, gene expression analysis identified mammalian target of rapamycin signalling as being activated after deletion of Hdac3, and inhibition by rapamycin affected the accumulation of neutral lipids in Hdac3-null livers. Thus, Hdac3 regulates metabolism through multiple signalling pathways in the liver, and deletion of Hdac3 disrupts normal metabolic homeostasis.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available